News | July 04, 2023
Anupam Rasayan signs MoU with 3xper Innoventure for new age pharma molecules
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
Phase-III trials were conducted for safety, and immunogenicity in around 3,100 subjects, in 14 trial sites across India (supported by BIRAC)
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity
Prime Minister said that it is a huge day for health in Gujarat and congratulated everyone associated with these projects for completing them on time.
Subscribe To Our Newsletter & Stay Updated
